Lorea Manterola

2.8k total citations
27 papers, 1.8k citations indexed

About

Lorea Manterola is a scholar working on Molecular Biology, Cancer Research and Small Animals. According to data from OpenAlex, Lorea Manterola has authored 27 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Cancer Research and 5 papers in Small Animals. Recurrent topics in Lorea Manterola's work include MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (7 papers) and Brucella: diagnosis, epidemiology, treatment (5 papers). Lorea Manterola is often cited by papers focused on MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (7 papers) and Brucella: diagnosis, epidemiology, treatment (5 papers). Lorea Manterola collaborates with scholars based in Spain, United Kingdom and Costa Rica. Lorea Manterola's co-authors include Charles H. Lawrie, Carla Solé, David Otaegui, Esther Arnaiz, Leire Iparraguirre, Ignacio López‐Goñi, Ignacio Moriyón, Marta Fernández‐Mercado, María Arestin and Edgardo Moreno and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Hepatology.

In The Last Decade

Lorea Manterola

27 papers receiving 1.8k citations

Peers

Countries citing papers authored by Lorea Manterola

Since Specialization

Citations

This map shows the geographic impact of Lorea Manterola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorea Manterola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorea Manterola more than expected).

Fields of papers citing papers by Lorea Manterola

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorea Manterola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorea Manterola. The network helps show where Lorea Manterola may publish in the future.

Co-authorship network of co-authors of Lorea Manterola

This figure shows the co-authorship network connecting the top 25 collaborators of Lorea Manterola. A scholar is included among the top collaborators of Lorea Manterola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorea Manterola. Lorea Manterola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting oncogenic functions of miR-301a in head and neck squamous cell carcinoma by PI3K/PTEN and MEK/ERK pathways 2023 ·Biomedicine & Pharmacotherapy ·Rocío Granda‐Díaz, Lorea Manterola, Francisco Hermida‐Prado, René Rodrı́guez, Laura Santos, (unknown), María Teresa Fernández‐Rodrigo, (unknown), Juan P. Rodrigo, Saúl Álvarez–Teijeiro, Charles H. Lawrie, Juana García-Pedrero	9
2	Integrated mRNA and miRNA Transcriptomic Analyses Reveals Divergent Mechanisms of Sunitinib Resistance in Clear Cell Renal Cell Carcinoma (ccRCC) 2021 ·Cancers ·María Armesto, (unknown), María Arestin, Peio Errarte, (unknown), Lorea Manterola, José I. López, Charles H. Lawrie	8
3	The Urinary Transcriptome as a Source of Biomarkers for Prostate Cancer 2020 ·Cancers ·Carla Solé, Ibai Goicoechea, (unknown), (unknown), María Armesto, María Arestin, Lorea Manterola, (unknown), (unknown), Léonor Nogueira, M. Roumiguié, José I. López, (unknown), Ander Urruticoechea, Itziar Vergara, Ana Loizaga‐Iriarte, Miguel Unda, Arkaitz Carracedo, Bernard Malavaud, Charles H. Lawrie	17
4	The circulating transcriptome as a source of cancer liquid biopsy biomarkers 2019 ·Seminars in Cancer Biology ·Carla Solé, Esther Arnaiz, Lorea Manterola, David Otaegui, Charles H. Lawrie	96
5	CircRNAs and cancer: Biomarkers and master regulators 2018 ·Seminars in Cancer Biology ·Esther Arnaiz, Carla Solé, Lorea Manterola, Leire Iparraguirre, David Otaegui, Charles H. Lawrie	317
6	PO-471 Circular RNA detection in melanoma patients’ plasma 2018 ·ESMO Open ·Esther Arnaiz, Ibai Goicoechea, Iñigo Prada-Luengo, Lorea Manterola, Pablo L. Ortiz‐Romero, David Otaegui, Charles H. Lawrie	1
7	Noncoding RNA Expression and Targeted Next-Generation Sequencing Distinguish Tubulocystic Renal Cell Carcinoma (TC-RCC) from Other Renal Neoplasms 2017 ·Journal of Molecular Diagnostics ·Charles H. Lawrie, María Armesto, Marta Fernández‐Mercado, María Arestin, Lorea Manterola, Ibai Goicoechea, Erika Larrea, María M. Caffarel, Angela M. Araujo, Carla Solé, Māris Sperga, Isabel Alvarado‐Cabrero, Michal Michal, Ondřej Hes, José I. López	18
8	Expression and activity of angiotensin-regulating enzymes is associated with prognostic outcome in clear cell renal cell carcinoma patients 2017 ·PLoS ONE ·Peio Errarte, Maider Beitia, Itxaro Pérez, Lorea Manterola, Charles H. Lawrie, (unknown), (unknown), Miguel Unda, José I. López, Gorka Larrinaga	33
9	Dysregulation of Mir-196b in Head and Neck Cancers Leads to Pleiotropic Effects in the Tumor Cells and Surrounding Stromal Fibroblasts 2017 ·Scientific Reports ·Saúl Álvarez–Teijeiro, Sofía T. Menéndez, M. Ángeles Villaronga, Juan P. Rodrigo, Lorea Manterola, Lucas de Villalaín, Juan Carlos de Vicente, (unknown), María P. Fernández, Charles H. Lawrie, Juana García-Pedrero	29
10	mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance 2016 ·Expert Opinion on Therapeutic Targets ·(unknown), Paula Aldaz, Olatz Arrizabalaga, Verónica Moncho-Amor, Estefanía Carrasco‐García, Lorea Manterola, Leire Moreno‐Cugnon, Cristina Barrena, Jorge Villanúa, Irune Ruiz, Steven M. Pollard, Robin Lovell‐Badge, Nicolàs Samprón, Idoia García, Ander Matheu	109
11	MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential 2015 ·Current Genomics ·Marta Fernández‐Mercado, Lorea Manterola, Charles H. Lawrie	23
12	1–42 β-Amyloid peptide requires PDK1/nPKC/Rac 1 pathway to induce neuronal death 2013 ·Translational Psychiatry ·Lorea Manterola, Miriam Hernando-Rodríguez, Asier Ruiz, Aintzane Apraiz, (unknown), Luciano Vellón, Elena Alberdi, Fabio Cavaliere, Hadriano M. Lacerda, Sebastián Jiménez, (unknown), Carlos Matute, José L. Zugaza	41
13	Targeted next‐generation sequencing and non‐coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes 2013 ·The Journal of Pathology ·Charles H. Lawrie, Erika Larrea, Gorka Larrinaga, Ibai Goicoechea, María Arestin, Marta Fernández‐Mercado, Ondřej Hes, (unknown), Lorea Manterola, José I. López	44
14	Oncogenicity of the Developmental Transcription Factor Sox9 2012 ·Cancer Research ·Ander Matheu, Manuel Collado, Clare Wise, Lorea Manterola, Lina Cekaite, (unknown), Marta Cañamero, Luís Bujanda, Andreas Schedl, Kathryn S.E. Cheah, Rolf I. Skotheim, Ragnhild A. Lothe, Adolfo López de Munain, James Briscoe, Manuel Serrano, Robin Lovell‐Badge	168
15	Bortezomib action in multiple myeloma: microRNA-mediated synergy (and miR-27a/CDK5 driven sensitivity)? 2012 ·Blood Cancer Journal ·Erica Ballabio, María Armesto, (unknown), Lorea Manterola, María Arestin, Daniela Tramonti, Christian S. R. Hatton, Charles H. Lawrie	27
16	Genetic and Epigenetic Modifications of Sox2 Contribute to the Invasive Phenotype of Malignant Gliomas 2011 ·PLoS ONE ·Marta M. Alonso, Ricardo Díez-Valle, Lorea Manterola, Ángel Rubio, Dan Liu, Nahir Cortes‐Santiago, (unknown), (unknown), Adolfo López de Munaín, Nicolàs Samprón, (unknown), Sonia Tejada-Solís, Carmen Vicente, María D. Odero, Eva Bandrés, Jesús García‐Foncillas, Miguel Á. Idoate, Frederick F. Lang, Juàn Fueyo, Candelaria Gomez‐Manzano	177
17	Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10 2010 ·Hepatology ·Nancy Díaz‐Valdés, Lorea Manterola, Virginia Belsúe, José Ignacio Riezu‐Boj, Esther Larrea, (unknown), Diana Llópiz, Jacinto López‐Sagaseta, Hervé Lerat, Jean–Michel Pawlotsky, Jesús Prìeto, Juan José Lasarte, Francisco Borrás‐Cuesta, Pablo Sarobe	23
18	Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants 2006 ·Vaccine ·María Jesús Grilló, Lorea Manterola, María Jesús de Miguel, Pilar M. Muñoz, J.M. Blasco, Ignacio Moriyón, Ignacio López‐Goñi	42
19	Regulation of Brucella virulence by the two-component system BvrR/BvrS 2002 ·Veterinary Microbiology ·Ignacio López‐Goñi, Caterina Guzmán‐Verri, Lorea Manterola, Alberto Sola‐Landa, Ignacio Moriyón, Edgardo Moreno	67
20	Evaluation of a PCR test for the diagnosis of Brucella ovis infection in semen samples from rams 2002 ·Veterinary Microbiology ·Lorea Manterola, (unknown), (unknown), (unknown), J.M. Blasco, C. M. Marín, Ignacio López‐Goñi	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact